Iovate signs deal to use synthesized capsaicin analogue in weight management products

Connect with us

Branded as aXivite, the ingredient is the first nutraceutical category offering of the Norwegian firm aXichem AB, which is based in Bergen. The ingredient is phenylcapsaicin, a chemically synthesized analogue of capsaicin.  It has Novel Foods status in the EU and GRAS status in the United States.

Branded as aXivite, the ingredient is the first nutraceutical category offering of the Norwegian firm aXichem AB, which is based in Bergen. The ingredient is phenylcapsaicin, a chemically synthesized analogue of capsaicin.  It has Novel Foods status in the EU and GRAS status in the United States.

Micro encapsulated ingredient claimed to show better bioavailability

The company also advertises that the ingredient, which has a similar pungency to natural capsaicin, is micro encapsulated to make it more palatable.  It is also claimed to be up to eight times more bioavailable than natural capsaicin.

Iovate said in a statement that aXivite will be incorporated into different brands within the Iovate portfolio, including the number one weight management brand in the US, which has sold over 100 million units to date. The first Iovate product containing aXivite will be introduced in late 2022. In addition to the supply agreement, the parties agree to co-fund further research on aXivite.

Michigan firm to distribute ingredient

The Norwegian brand holders market their products in North America via branded ingredient firm SEE Nutrition.  Based in Ann Arbor, MI, SEE Nutrition also distributes a couple of ingredients manufactured by Spanish firm Bioiberica.

“We are very excited about working with Iovate and aXichem on this project, bringing this very unique ingredient to North American consumers,” ​said Elias Chiatalas, CEO of SEE Nutrition.

Leave a Reply

Your email address will not be published.